ArticleBiomedicines2022

Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer.

Naamit Deshet-Unger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.